Skip to content-
Q3 Earnings 2026
A word from our CEO Our goal in writing these quarterly letters is to provide you a summary of our financial and operating results, along with some context as to how we view those results. Q3 was an [...]
-
Q2 Earnings 2026
A word from our CEO Our goal in writing these quarterly letters is to provide you a summary of our financial and operating results, along with some context as to how we view those results. Q2 was an [...]
-
Q1 Earnings 2026
A word from our CEO Our goal in writing these quarterly letters is to provide you a summary of our financial and operating results, along with some context as to how we view those results. We had [...]
-
See Spot Run
When I started Tempus, I knew that technology would disrupt healthcare. I had enough exposure to the impact technology had on other industries to see that writing on the wall. But unlike other [...]
-
Q4 and Full Year 2025 Overview
A word from our CEO Our goal in writing these quarterly letters is to provide you a summary of our financial and operating results, along with some context as to how we view those results. We had [...]
-
The Fix
In October of 2024, I wrote a blog called “The Black Hole” which described the escalating costs of healthcare that at the time were taxing the US economy with total costs exceeding $4.8 trillion [...]
-
Introduction to Tempus’ Innovate 2025
-
A Look Back
In December of 2023, about 6 months before we went public, we changed our name from Tempus Labs, Inc. to Tempus AI, Inc. At the time, I thought it made sense, as we had long since evolved from being [...]
-
HumanX
-
Fox Business
Watch the latest video at foxbusiness.com Tempus Founder and CEO Eric Lefkofsky discusses bringing AI to diagnostics on ‘The Claman Countdown’